Medtronic has announced the first subject enrolment in the Peripheral Onyx Liquid Embolic (PELE) trial. The study aims to ...

Medtronic's Jason Fontana offers an update on next-generation Symplicity Spyral devices, procedures and a new feature they're ...

With EU CE mark clearance for LigaSure RAS, Medtronic expands the Hugo system’s capabilities in gynaecologic and urologic ...

Medtronic (NYSE: MDT) today announced the first patient enrolled in the PELE trial of its Onyx liquid embolic system (LES).

Johnson & JohnsonJNJ stock jumped Wednesday after the Dow Jones health behemoth raised its 2025 guidance in the wake of a bullish second-quarter report.For the year, J&J now expects adjusted earnings ...

Medtronic said its market-leading LigaSure technology can now be used with its Hugo soft tissue robotic surgery system in ...

Right now one of the best healthcare stocks to look at is medical device giant Medtronic ( MDT 0.39%), which is offering a ...

Medtronic has worked with nonprofit SpineHope to give more than 200 children life-changing medical treatment since 2008 ...

Medtronic announced today that it received CE mark for its LigaSure vessel sealing technology for use with its Hugo system.

CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward ...

Medtronic announced it has entered into an exclusive United States distribution agreement with Japan-based Future Medical Design C ...

Medtronic reported that it has begun testing an expansion of its renal denervation approach for dropping stubbornly high ...